Galapagos | Stammkapital



Ordinary Share Capital Veränderung Datum
argenx SE 61.17M 405.3K 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Biogen USD 146.6M 146.5M 2025-06
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1.24B 3M 2025-06
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
GRIFOLS EUR 680.41M 560.8M 2025-06
Hikma Pharmaceutical USD 40M 0 2024-12
Incyte USD 194.12M 193.93M 2025-06
Merck EUR 434.78M 130.22M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
UCB EUR 584M 0 2024-12
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Galapagos Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.